Marie® by Leo Cancer Care Makes History at Stanford Medicine — World First in Compact Upright Proton Therapy
9.6.2026 15:22:00 CEST | Business Wire | Press Release
Following the landmark first treatment at Stanford Medicine Cancer Center Care June 4, Leo Cancer Care today announces the role of its Marie® upright patient positioning and imaging platform in enabling the world's first compact upright proton therapy patient treatment. Delivered using the Mevion S250-FIT™ Proton Therapy System and powered by RayStation from RaySearch, the milestone is the culmination of a decade of development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609870736/en/
The treatment room at Stanford Medicine Cancer Center, Palo Alto, California, housing the Marie® upright patient positioning platform by Leo Cancer Care (center foreground) integrated with the Mevion S250-FIT™ Proton Therapy System. The circular rotating platform enables a patient seated in the Marie® chair to rotate 360 degrees in relation to a fixed proton beam — replacing the large rotating gantries required by traditional proton therapy systems. This compact configuration, which requires approximately 1,700 square feet compared with over 29,000 square feet for conventional proton therapy facilities, was used on June 4, 2026 to complete the world's first compact upright proton therapy patient treatment. The Marie® system is powered by RayStation from RaySearch. Photo: Steve Fisch / Stanford Medicine
From Innovation to Adoption
Leo Cancer Care was built on a straightforward belief: that people living with cancer deserve a treatment experience designed around them — not around the machine. That belief drove the development of Marie®, and the first clinical deployment of this combined compact proton therapy and upright positioning approach is its proof point. Upright radiotherapy is not a new concept; Leo Cancer Care has spent a decade ensuring that its potential becomes a clinical reality, and that the lessons of the past inform the breakthroughs of the future.
The momentum behind that journey had already drawn significant attention. In October 2025, Forbes headlined their coverage of Leo Cancer Care: "How A High-Tech Chair Could Revolutionize Cancer Radiation Therapy" — noting that the system's compact design reduces the space required for proton therapy by more than 90 percent, from over 29,000 square feet to approximately 1,700 square feet. The latest milestone is the clinical validation of that prediction.
For children, whose developing bodies are particularly sensitive to radiation, proton therapy's ability to target treatment with greater precision can be especially significant. Yet for most families, proton therapy has simply not been an option. Traditional systems require large rotating gantries and dedicated purpose-built facilities, placing them out of reach for the vast majority of cancer centres worldwide. For a child requiring weeks of daily treatment, the nearest facility may be hundreds of miles away — a distance that carries a very human cost.
The Marie® platform addresses this by rotating the patient in relation to a fixed proton beam rather than rotating a large gantry around them. This can enable proton therapy systems to be installed within existing radiotherapy vaults — expanding the reach of this treatment to places it has never been before.
The More Human Way to Deliver Radiotherapy
Marie® was designed from a simple starting point: what does the person in treatment actually need? The upright position is where we spend two-thirds of our lives — standing, sitting, moving. Treating patients in that natural position is not a rejection of conventional radiotherapy; it is an expansion of what radiotherapy can be. Less daunting. More comfortable. More human.
Marie® is being explored for its potential to improve patient comfort and enable faster patient set-up. The upright approach enables eye-to-eye interaction between patients and clinical teams throughout the treatment process — something that has not previously been possible within a radiotherapy setting, and which takes on particular significance when the patient is a child.
To further support younger patients, Leo Cancer Care has developed StatueQuest, a unique interactive adventure game designed for pediatric patients — one more expression of the company's belief that every part of the treatment experience should be designed with the person at its centre.
Preliminary evaluations of upright positioning have indicated strong patient acceptance, with participants reporting comfortable breathing, ease of positioning, and a preference for the upright treatment experience.
Marie® features a 360-degree rotating patient positioning system with integrated upright CT imaging, enabling proton therapy to be delivered with initial image guidance directly at the treatment position. At Stanford Medicine, Marie® is integrated with the Mevion S250-FIT™ system to create a compact proton therapy configuration that supports installation within existing radiotherapy vaults.
"This milestone represents an important moment not only for Leo Cancer Care, but for the future direction of radiation oncology. For decades, proton therapy has delivered remarkable clinical benefits but has remained limited by the scale, complexity, and infrastructure demands of traditional systems. By enabling treatment in an upright position using a fixed-beam approach, we are helping redefine how proton therapy can be delivered — making it more compact, more flexible, and potentially accessible to far more patients around the world."
— Stephen Towe, CEO, Leo Cancer Care
What's Next
The Stanford Medicine installation represents the first clinical deployment of this combined compact proton therapy and upright positioning approach. The site is exploring treatment delivery with patients positioned upright, alongside continued evaluation of workflow, immobilisation, and planning flexibility. As additional patients are treated, the human story at the heart of this milestone will only deepen.
The commercial implications extend well beyond a single installation. By enabling proton therapy deployment within existing radiotherapy vaults, Leo Cancer Care's approach dramatically lowers the capital threshold that has historically confined proton therapy to a small number of specialist centres — opening it to a significantly larger addressable market of institutions that could never previously have considered it.
Following this milestone, Leo Cancer Care will continue working with clinical and technology partners to support further installations and ongoing research into upright radiotherapy delivery. The collaboration between Leo Cancer Care and Mevion Medical Systems is expected to support broader adoption of compact proton therapy solutions across additional centres globally.
ABOUT LEO CANCER CARE
It's estimated that we spend two-thirds of our lives upright, standing, sitting, or moving in our natural position. At Leo Cancer Care, we are committed to challenging the conventions of radiation oncology by reintroducing upright treatment to radiotherapy practice.
Our Marie® suite of upright positioning and imaging solutions was created with two complementary goals: transforming the patient experience and expanding access to advanced radiotherapy. By shifting from machine rotation to patient rotation, Leo Cancer Care enables more compact treatment environments while allowing patients to remain in a more natural and comfortable position.
This approach supports improved patient interaction, potential motion reduction, and more flexible treatment delivery, while also helping healthcare providers overcome infrastructure and cost barriers associated with traditional systems.
Leo Cancer Care is proud to be working alongside leading healthcare institutions and industry partners to support the evolution of radiotherapy — enabling more accessible, sustainable, and patient-centered cancer treatment worldwide.
NOTES TO EDITORS
Stanford Medicine first patient story: https://med.stanford.edu/news/all-news/2026/06/proton-therapy.html
Forbes coverage, October 2025 (Amy Feldman): https://www.forbes.com/sites/amyfeldman/2025/10/16/how-a-high-tech-chair-could-revolutionize-cancer-radiation-therapy/
View source version on businesswire.com: https://www.businesswire.com/news/home/20260609870736/en/
Contacts
MEDIA CONTACT
Ann Claire Pahlavi, Senior Communications Advisor
E: annclaire@annclairemedia.com
W: https://leocancercare.com -
https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fleocancercare.
com&esheet=54550113&newsitemid=20260609870736&lan=en-US&anchor=https%3A%2F%2Fleo
cancercare.com&index=5&md5=064fb42f2cc19ffd4c2ef028824d92b7
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
H55 Delivers Certification-Grade Propulsion Battery Modules to Pratt & Whitney Canada, Supporting Demonstration of Hybrid-Electric Aircraft Technology9.6.2026 17:31:00 CEST | Press Release
H55 today announced the delivery of certification-grade propulsion battery modules to Pratt & Whitney Canada in support of the RTX Hybrid-Electric Flight Demonstrator — a milestone that further validates H55’s transition from technology development to industrial-scale execution and represents an important step in the commercialization of the company’s certification-grade energy storage technologies for hybrid-electric aerospace applications. Pratt & Whitney is an RTX business. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609825006/en/ H55 Adagio Battery Modules in Pratt & Whitney Canada Hangar ©RTX The delivery represents more than hardware integration. It demonstrates H55’s ability to manufacture production-conforming propulsion systems within a regulator-approved environment and deploy them into active aircraft integration and flight-test programs — a capability achieved today by only a small number of companies globa
New Polymorph of Indomethacin Discovered9.6.2026 17:00:00 CEST | Press Release
Rigaku Corporation, a global solution partner in X-ray analytical systems and a group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; “Rigaku”), announced that the results of a joint research project conducted with Shionogi & Co., Ltd., JEOL Ltd., and Meiji Pharmaceutical University have been published in Crystal Growth & Design, a world-renowned international journal in the field of crystallography. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260609347405/en/ Cover of the June 2026 issue of Crystal Growth & Design, featuring this research. This research uncovered a previously unknown polymorph (κ-form) of indomethacin, a widely used pain relief and anti-inflammatory drug. The research team also conducted structural analysis and characterization of the newly identified crystal form. Although indomethacin has been the subject of pharmaceutical research for years, the discovery of a
SLB Collaborates with Qualcomm on Edge AI Solutions for Energy Operations9.6.2026 16:28:00 CEST | Press Release
Global energy technology company SLB (NYSE: SLB) today announced a memorandum of understanding with Qualcomm Technologies, Inc. to enable edge AI solutions for the energy industry, supporting real-time operational decision-making across wells, facilities and production systems. The collaboration combines Qualcomm Technologies’ low-power edge computing and AI processing capabilities, with SLB’s Agora™ edge AI and IoT solutions developed for remote and operationally complex environments. “Together, SLB and Qualcomm Technologies aim to help operators apply AI more effectively across energy infrastructure,” said Rakesh Jaggi, president, Digital, SLB. “Many energy operations rely on real-time decision-making in remote environments where connectivity and responsiveness directly affect performance. AI systems designed around the realities of energy operations can help support more consistent and autonomous workflows across those environments.” Energy operators are increasingly adopting automa
RevBits and Stony Brook University’s Ethos Lab Establish a Collaborative Partnership to Further the Field of Cyber Security Education and Application9.6.2026 16:15:00 CEST | Press Release
Stony Brook University’s (SBU) Ethos Lab, in the College of Engineering and Applied Sciences Department of Computer Science, recently announced a collaborative partnership with RevBits, LLC. Through the partnership, SBU’s Ethos Lab will utilize the RevBits solutions suite to build computer science labs and a cybersecurity-focused curriculum, reinforcing lessons from the classroom. The platform simulates environments containing five major threat landscapes, including Endpoint Security, Privileged Access Management, Email Security, Zero Trust Network and Deception Technology. SBU’s Department of Computer Science was recently designated as a National Center of Academic Excellence in Cybersecurity Research and will utilize the partnership to advance student education and equip them with the knowledge to face modern threats in a realistic, contained environment. David Schiffer, CEO, RevBits, said, "We are incredibly proud to participate in the educational process in general and specifically
Andersen Global Strengthens Global Mobility Capabilities with Addition of Courdid BV9.6.2026 15:30:00 CEST | Press Release
Andersen Global has entered into a Collaboration Agreement with Courdid BV, a Netherlands-based global mobility firm, further strengthening its cross-border workforce and expatriate advisory capabilities. Founded nearly two decades ago, Courdid BV offers a comprehensive suite of advisory services spanning wage tax, expatriate taxation, payroll, immigration, and employer of record solutions. The firm partners with multinational employers, public sector entities, and professional service providers to deliver practical, tailored guidance on complex cross-border workforce matters — distinguished by a client-first approach that prioritizes accessibility and personal service. “We believe in keeping things practical and relevant for our clients, particularly in areas that are often overly complex,” said Jean-Paul van ‘t Hof, managing partner of Courdid BV. “Becoming a collaborating firm of Andersen Global allows us to support clients more broadly while strengthening our ability to address cro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom